These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15664161)

  • 41. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding the drivers of MHC restriction of T cell receptors.
    La Gruta NL; Gras S; Daley SR; Thomas PG; Rossjohn J
    Nat Rev Immunol; 2018 Jul; 18(7):467-478. PubMed ID: 29636542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The orientation of a T cell receptor to its MHC class II:peptide ligands.
    Hong SC; Sant'Angelo DB; Dittel BN; Medzhitov R; Yoon ST; Waterbury PG; Janeway CA
    J Immunol; 1997 Nov; 159(9):4395-402. PubMed ID: 9379037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell receptor crossreactivity as a general property of T cell recognition.
    Wucherpfennig KW
    Mol Immunol; 2004 Feb; 40(14-15):1009-17. PubMed ID: 15036904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex.
    Vasmatzis G; Cornette J; Sezerman U; DeLisi C
    J Mol Biol; 1996 Aug; 261(1):72-89. PubMed ID: 8760503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules.
    Leddon SA; Sant AJ
    Curr Opin Organ Transplant; 2010 Aug; 15(4):505-11. PubMed ID: 20616724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR.
    Daniel C; Horvath S; Allen PM
    Immunity; 1998 May; 8(5):543-52. PubMed ID: 9620675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-affinity T cell receptor differentiates cognate peptide-MHC and altered peptide ligands with distinct kinetics and thermodynamics.
    Persaud SP; Donermeyer DL; Weber KS; Kranz DM; Allen PM
    Mol Immunol; 2010 May; 47(9):1793-801. PubMed ID: 20334923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor.
    Kumar A; Delogu F
    Sci Rep; 2017 Feb; 7():42496. PubMed ID: 28195200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
    Wang JH; Meijers R; Xiong Y; Liu JH; Sakihama T; Zhang R; Joachimiak A; Reinherz EL
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10799-804. PubMed ID: 11535811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genome-wide structural modelling of TCR-pMHC interactions.
    Liu IH; Lo YS; Yang JM
    BMC Genomics; 2013; 14 Suppl 5(Suppl 5):S5. PubMed ID: 24564684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective contact during TCR recognition.
    Feng MH; Shen YC; Chou DL; Lai MZ; Liaw YC
    Int Immunol; 1996 Jan; 8(1):45-55. PubMed ID: 8671588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A previously unappreciated polymorphism in the beta chain of I-A
    Richards KA; Lavery C; Keller GLJ; Miller J; Baker BM; Sant AJ
    Mol Immunol; 2022 Mar; 143():17-26. PubMed ID: 34995990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unusual features of self-peptide/MHC binding by autoimmune T cell receptors.
    Nicholson MJ; Hahn M; Wucherpfennig KW
    Immunity; 2005 Oct; 23(4):351-60. PubMed ID: 16226501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DynaDom: structure-based prediction of T cell receptor inter-domain and T cell receptor-peptide-MHC (class I) association angles.
    Hoffmann T; Marion A; Antes I
    BMC Struct Biol; 2017 Feb; 17(1):2. PubMed ID: 28148269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deconstructing the peptide-MHC specificity of T cell recognition.
    Birnbaum ME; Mendoza JL; Sethi DK; Dong S; Glanville J; Dobbins J; Ozkan E; Davis MM; Wucherpfennig KW; Garcia KC
    Cell; 2014 May; 157(5):1073-87. PubMed ID: 24855945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability.
    Burrows SR; Chen Z; Archbold JK; Tynan FE; Beddoe T; Kjer-Nielsen L; Miles JJ; Khanna R; Moss DJ; Liu YC; Gras S; Kostenko L; Brennan RM; Clements CS; Brooks AG; Purcell AW; McCluskey J; Rossjohn J
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10608-13. PubMed ID: 20483993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II.
    Li Y; Li H; Dimasi N; McCormick JK; Martin R; Schuck P; Schlievert PM; Mariuzza RA
    Immunity; 2001 Jan; 14(1):93-104. PubMed ID: 11163233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones.
    Ausubel LJ; Kwan CK; Sette A; Kuchroo V; Hafler DA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15317-22. PubMed ID: 8986809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.